Moderna

Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule... Wikipedia

• Formerly called:  ModeRNA Therapeutics (2010–2018)
• Type:  Public
• Traded as:  NASDAQ: MRNA, S&P 500 component
• ISIN:  [ ISIN: [ US60770K1079]]
• Industry:  Biotechnology
• Founders:  Derrick Rossi, Timothy A. Springer, Robert S. Langer, Kenneth R. Chien, Noubar Afeyan
• Key people:  Stéphane Bancel (CEO), Noubar Afeyan (chairman), Stephen Hoge (president), Jamey Mock (CFO)
• Products:  Spikevax, Vaccine candidates
• Revenue:  US$1.94 billion (2025)
• Operating income:  US$-3.1 billion (2025)
• Total assets:  US$12.3 billion (2025)
• Total equity:  US$8.65 billion (2025)
• Owners:  Stéphane Bancel (7.3%), Noubar Afeyan (5.0%), Robert S. Langer (4.0%), Stephen Hoge (1.3%)
• Number of employees:  4,800(2025)
• Website:  modernatx.com
• Data source:  DuckDuckGo